Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-126812
Filing Date
2025-12-31
Accepted
2025-12-31 08:00:08
Documents
5
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0271399-6k_ascent.htm 6-K 11511
2 ANNOUNCEMENT DATED DECEMBER 30, 2025 ea027139901ex99-1_ascent.htm EX-99.1 15711
3 ANNOUNCEMENT DATED DECEMBER 30, 2025 ea027139901ex99-2_ascent.htm EX-99.2 10575
4 GRAPHIC ex99-1_001.jpg GRAPHIC 5614
5 GRAPHIC ex99-2_001.jpg GRAPHIC 5578
  Complete submission text file 0001213900-25-126812.txt   54678
Mailing Address 68 XINQING ROAD SUZHOU INDUSTRIAL PARK SUZHOU , JIANGSU China
Business Address 68 XINQING ROAD SUZHOU INDUSTRIAL PARK SUZHOU , JIANGSU China 86 512 8555 7777
ASCENTAGE PHARMA GROUP INTERNATIONAL (Filer) CIK: 0002023311 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42484 | Film No.: 251615744
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)